Cell Reactant:
RNA(23-mer)
Syringe Reactant:
BDBM19
Meas. Tech.:
ITC
Entry Date.:
12/19/00
ΔG°:
-6.4±n/a (kcal/mole)
pH:
7±n/a
Log10Kb:
0.1
Temperature:
298.15±n/a (K)
ΔH° :
-17.28±n/a (kJ/mole)
ΔHobs :
-17.28±n/a (kJ/mole)
ΔS° :
-0.02±n/a (kJ/mole-K)
Comments:
low affinity site
Citation
 Cowan, JAOhyama, TWang, DNatarajan, K Recognition of a cognate RNA aptamer by neomycin B: quantitative evaluation of hydrogen bonding and electrostatic interactions. Nucleic Acids Res 28:2935-42 (2000) [PubMed]  Article
Cell React
Source:
in vitro transcription using T7 RNA polymerase
Prep. Method:
purified using PAGE and electroeluted from the gel
Name:
RNA(23-mer)
Synonyms:
RNA 23mer
Type:
RNA
Mol. Mass.:
1388.55
Organism:
n/a
Description:
n/a
Residue:
19
Sequence:
GGCCGGGCGAGAAGAGGCC
 
Syringe React
Source:
Sigma (St. Louis, MO)
Name:
BDBM19
Synonyms:
(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(2R,3S,4R,5S)-5-{[(1R,2R,3S,5R,6S)-3,5-diamino-2-{[(2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-hydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}oxane-3,4-diol | KDR Kinase Inhibitor, 3 | Neomycin | Neomycin B
Type:
Small organic molecule
Emp. Form.:
C23H46N6O13
Mol. Mass.:
614.6437
SMILES:
NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O |r|
Structure:
Search PDB for entries with ligand similarity: